Recent News and Articles on the Keywords: prostate + risk + cancer  Related to the article below (Last Update: 8/7/2008)

Canada.com Routine prostate screens 'premature' The Age, Australia - US experts say there is enough evidence to start routinely testing middle-aged men for early signs of prostate cancer, but Australian specialists say this ... Why should 75 years old men avoid prostate cancer screening? Food Consumer What 9 Types of Men Should Do About Prostate Cancer Screening U.S. News & World Report Prostate cancer screening not recommended for men over 75 Xinhua The Age - U.S. News & World Report all 769 news articles » Study Links Agent Orange to Prostate Cancer in Vietnam Vets Washington Post, United States - 6 (HealthDay News) -- Vietnam veterans exposed to the defoliant Agent Orange have a significantly greater risk of prostate cancer, especially the most ... Exposure To Agent Orange Linked To Prostate Cancer In Vietnam Veterans Science Daily (press release) Agent Orange Linked to Prostate Cancer Military.com all 37 news articles » Prostate Cancer Canada.com, Canada - Various factors can increase or reduce the chance of mutations, and therefore cancer. The following factors are believed to increase the risk of prostate ... Telegraph.co.uk Prince Philip in prostate health scare Telegraph.co.uk, United Kingdom - "The Duke of Edinburgh has authorised us to confirm that the claim made by the Evening Standard that he has received a 'diagnosis of prostate cancer' is ... Prince Philip has prostate cancer? Health24.com Philip defies prostate scare This is London Philip cancer report is untrue, says Palace Independent Grimsby Evening Telegraph all 412 news articles » Physical Development Rate May Be Tied To Prostate Cancer Risk Cancerpage.com, GA - These results, the team concludes, "support a role for the indicators of somatic development and adolescent body size in predicting prostate cancer risk, ... Brachytherapy Vs. Cryoablation In The Treatment Of Prostate Cancer Medical News Today (press release), UK - Cohen JK, Miller RJ, Ahmed S, Lotz MJ, Baust J Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary ... Delay in body growth linked to prostate cancer Reuters - Aug 5, 2008 "The study has underlined the potential effect of the 'timing' at exposure of sexual and (body growth) variables on the risk of prostate cancer," senior ... deCODE genetics Announces Second Quarter 2008 Financial Results MarketWatch - The American Cancer Society now recommends that women who are at a 20-50% above-average risk of breast cancer should consider undergoing annual ...DCGN Cancer: World`s worst killer Triumph, Nigeria - The commonest forms of cancer are breast cancer, prostate cancer and skin cancer. Others include lung cancer, colon cancer, endometrial cancer, ... Black-White Differences Again Seen in Prostate Cancer Prognosis Cancerpage.com, GA - ... overall survival (risk ratio, 1.35) that was not due to comorbidity alone as both prostate cancer-specific mortality and biochemical recurrence showed a ...

Olive oil pill can cut prostate cancer risk

A pill made from olive oil and herbs could dramatically reduce a man's chances of developing prostate cancer.

A trial at Columbia University in the US revealed the herbal supplement can reduce the rate at which prostate cancer cells grow and spread by nearly 80 per cent.

The results, published in the medical journal Nutrition And Cancer, appear to confirm anecdotal evidence that the herbal mixture has powerful anti-cancer properties.

Called Zyflamend, the supplement is based on olive oil and ten different herbs.

It is already widely used as an alternative to prescription drugs in conditions such as arthritis. This is because it appears to reduce inflammation that causes painful, swollen joints.

Available through health food suppliers and costing around £25 for 60 capsules, Zyflamend attracted the attention of researchers at Columbia University after tests showed it stopped cancer cells multiplying.

Pill 'shows great promise'

But after testing the pill on almost 50 men, the team admitted they had not expected it to have such a potent effect.

"These results were particularly surprising and show greater promise in the fight against prostate cancer," said Dr Debra Bemis, who led the study.

"We hope the benefits shown will be confirmed in a larger scale trial already in progress."

Every year in Britain, around 27,000 men are diagnosed with prostate cancer. For many, the tumour grows so slowly it may never need treatment. But in others it spreads throughout the body.

The disease is on the increase in Britain, and although genetics are known to be a factor, studies show vegetarians are half as likely to get it as meat-eaters.

Treatments include surgery to remove the prostate, radiotherapy to kill cancer cells or hormone therapy, where testosterone levels in the body are reduced in order to starve the tumour.

In the search for ways to prevent the disease, most research has concentrated on lycopene - a substance found in tomatoes and shown to halt tumour growth.

But last year, the Columbia University team set up the first clinical trial to investigate the effects of Zyflamend.

Herbal mix

The supplement includes concentrated extracts from a range of common herbs and spices, such as turmeric, ginger, rosemary and oregano. Other ingredients include green tea extracts, a type of basil found only in India and herbs from Japan and China.

Several ingredients have been found to block the effects of an enzyme called cyclooxygenase-2, or COX-2. This is responsible for triggering inflammation throughout the body in conditions such as rheumatoid arthritis and heart disease.

Some experts believe it is also implicated in the development of certain cancers.

The US researchers studied the herbal pill's effects by looking at what impact it had on a condition called prostatic intraepithelial neoplasia, or PIN. This is where the top layers of cells of the prostate start to divide more rapidly than usual.

It's a pre-cancerous state that greatly increases the chances of a man going on to develop a tumour. A man with PIN has a 50 to 70 per cent chance of getting cancer.

Tests showed that the supplement dramatically slowed the rate at which pre-cancerous cells grew.

Dr Bemis said: "Zyflamend has shown an ability to reduce cancer cell proliferation by as much as 78 per cent, and to induce cancer cell death. These results are exceptionally promising."

The Prostate Cancer Charity's head of policy and research, Chris Hiley, said: "This research is in the very early stages. But it is significant that it may be able to stop men developing prostate cancer."